Company profile: NeuroRx
1.1 - Company Overview
Company description
- Provider of clinical trial services for new drugs in multiple sclerosis and other neurological diseases, including advanced MRI analysis; acquisition and analysis of non-conventional MRI (magnetization transfer imaging, magnetic resonance spectroscopy); MRI protocol guidance and manuals; compliant quantification forms; trial-specific scan tracking with validated database; site setup and supervision.
Products and services
- MRI Analysis: NeuroRx architects advanced MRI analysis, acquiring and interpreting non-conventional modalities—magnetization transfer imaging and magnetic resonance spectroscopy—to ensure precise quantitative measurements for neurological clinical trials
- Scan Tracking (NTT): NeuroRx constructs a trial-specific, validated scan-tracking tool and database, delivering scan handling and tracking services to monitor imaging submissions and maintain accurate records across clinical trials
- MRI Study Protocol Assistance: NeuroRx develops clinical-trial-focused MRI protocol guidance, selecting appropriate MRI outcome metrics and architecting study designs to harmonize imaging endpoints for multiple sclerosis and neurological disease trials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NeuroRx
Essex Management
HQ: United States
Website
- Description: Provider of biomedical informatics and health information technology services, including program and project management, systems design and engineering, computational biology, development of genetics and phenotypic databases, analytics/algorithm development, and data management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Essex Management company profile →
OctoPlus
HQ: The Netherlands
Website
- Description: Provider of specialty pharmaceutical expertise in the development of injectables. Based in a leading European bioscience park, the company is globally renowned and employs around 120 people representing over 20 nationalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OctoPlus company profile →
Legacy Packaging
HQ: United States
Website
- Description: Provider of pharmaceutical packaging services including bottle filling (30cc–1500cc), blister packaging (thermoform and coldform), and unit-of-use bottling under its own or client NDC codes with rebate management. Offers Ecoslide compliance packaging (senior-friendly, child-resistant), secondary packaging (cartoning, clamshell/blistershell filling, display assembly, inspection), and inline/offline serialization solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Legacy Packaging company profile →
Gallus BioPharma
HQ: United States
Website
- Description: Provider of contract manufacturing and development services for mammalian cell culture-derived biologics, supplying clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally, with capabilities in process and analytical development, process validation, cell banking, stability testing, QA/QC, regulatory support, and aseptic fill-finish (vial filling, inspection, labeling).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gallus BioPharma company profile →
North Georgia Clinical Research
HQ: United States
Website
- Description: Provider of FDA-approved clinical trials evaluating new treatments and medications for various health conditions, conducted at its Woodstock, GA facility. Studies include an Alzheimer's prevention study, cardiovascular and diabetes trials, elevated lipoprotein(a) research, and a high cholesterol study testing an oral investigational drug to lower LDL-C and reduce cardiovascular risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full North Georgia Clinical Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NeuroRx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NeuroRx
2.2 - Growth funds investing in similar companies to NeuroRx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NeuroRx
4.2 - Public trading comparable groups for NeuroRx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →